# Olema Pharmaceuticals, Inc.: Form 8-K, filed Oct 20, 2025

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2025-10-20
- Accepted by EDGAR: Oct 20, 2025, 21:13 ET
- Period: 2025-10-18
- Accession: 0001193125-25-243765
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000119312525243765/olma-20251018.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000119312525243765/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000119312525243765/olma-20251018.htm

Filed Oct 20, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-243765. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.